Project Grant R21CA301405
Award Date 8/1/25
Completion Date 7/31/27
Dollars Obligated $404K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New Jersey, USA
Similar Awards
- This $515,632 Project Grant from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports research to prepare the U.S. and states for potential new cigarette product standards that could significantly increase smoking cessation rates. The research team at the University of Minnesota will provide state-specific estimates of the number of people who smoke (PWS) that will quit smoking in response to a menthol ban and nicotine reduction standard, as well as the...
- The National Cancer Institute (NCI) awarded a $687,511 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to Rutgers, The State University of New Jersey. The grant supports a randomized trial to investigate the impact of charcoal-filtered cigarettes on product perceptions, smoking behaviors, and toxicant exposure. The study aims to provide ecologically valid data on the real-world effects of charcoal-filtered cigarettes, given concerns that prior studies using...
- The federal Project Grant award titled "Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit" is funded by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) for $663,554.00 with an award date of August 18, 2025 and an ultimate completion date of July 31, 2030. The grant supports research to explore the use of harm reduction product sampling, such as e-cigarettes, heated tobacco products, and oral...
- This federal Project Grant award of $429,399 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will fund research to "RECALIBRATE THE LUNG CANCER POLICY MODEL (LCPM) TO ADDRESS LUNG CANCER RISK AND LUNG CANCER SCREENING PRACTICES IN REAL-WORLD POPULATIONS." The goal is to improve the LCPM's accuracy in estimating the health and economic impacts of low-dose computed tomography (LDCT) lung cancer screening by 1) adjusting the model to reflect...
- This federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) will provide $220,193 to Rutgers, The State University of New Jersey to elucidate the role and mechanism of IFNE in KRAS-driven lung tumorigenesis. The award aims to determine the intrinsic and systemic functions of IFNE, a unique type I interferon, in KRAS-driven non-small cell lung cancer using genetically engineered mouse models. The research will investigate how aberrant expression...
- This federal Project Grant award of $619,175 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports a Type 1 hybrid effectiveness-implementation trial to evaluate a novel harm reduction approach for oncology outpatients who smoke but refuse traditional tobacco treatment. The study will directly compare rates of switching from cigarettes to e-cigarettes against standard care, while also assessing key barriers and facilitators to implementation. The...
- This Project Grant award of $226,504 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) supports research to understand tobacco use trajectories and related mechanisms among U.S. adults and youth representing minority and intersecting minority identities. The study aims to examine disparities in the use of diverse tobacco products, as well as the underlying mechanisms such as marketing exposure and product perceptions, within these populations. The research...
- This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) totaling $885,824 aims to assess consumer response to smokeless tobacco modified risk marketing orders. The research activities will explore 1) consumers' exposure and reactions to authorized smokeless tobacco modified risk tobacco product (MRTP) claims, and 2) whether the MRTP claims influence smokeless tobacco demand and sensory evaluations. The project will be conducted...
- This $2,991,283 Project Grant was awarded on September 23, 2025 by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. in Florida. The grant will fund a two-pronged research approach to (1) leverage a large electronic health record database to characterize trends and outcomes of lung cancer screening among people with and without HIV in the U.S., and (2) partner with community clinics serving...
- The U.S. National Cancer Institute (NCI) awarded a $158,290 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to Kaiser Foundation Hospitals to conduct a study on "Estimating Overdiagnosis After Implementation of Lung Cancer Screening in Community-Based Healthcare Systems." This 2-year project, running from July 2024 to July 2026, aims to produce estimates of overdiagnosis among patients diagnosed with lung cancer who participated in lung cancer...